SE8900564D0 - Novel medicinal use - Google Patents

Novel medicinal use

Info

Publication number
SE8900564D0
SE8900564D0 SE8900564A SE8900564A SE8900564D0 SE 8900564 D0 SE8900564 D0 SE 8900564D0 SE 8900564 A SE8900564 A SE 8900564A SE 8900564 A SE8900564 A SE 8900564A SE 8900564 D0 SE8900564 D0 SE 8900564D0
Authority
SE
Sweden
Prior art keywords
medicinal use
novel medicinal
novel
chlormethiazole
neurodegeneration
Prior art date
Application number
SE8900564A
Other languages
English (en)
Swedish (sv)
Inventor
B R Boar
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE8900564A priority Critical patent/SE8900564D0/xx
Publication of SE8900564D0 publication Critical patent/SE8900564D0/xx
Priority to IL9324390A priority patent/IL93243A/en
Priority to IE46090A priority patent/IE64622B1/en
Priority to PH40041A priority patent/PH26372A/en
Priority to AT90903980T priority patent/ATE107166T1/de
Priority to EP90903980A priority patent/EP0458892B1/en
Priority to JP2503995A priority patent/JP3007683B2/ja
Priority to DK90903980.2T priority patent/DK0458892T3/da
Priority to CA002045618A priority patent/CA2045618A1/en
Priority to AU51679/90A priority patent/AU643431B2/en
Priority to DE69009989T priority patent/DE69009989T2/de
Priority to NZ232499A priority patent/NZ232499A/xx
Priority to PCT/SE1990/000093 priority patent/WO1990009174A1/en
Priority to ES90903980T priority patent/ES2055421T3/es
Priority to KR91700916A priority patent/KR0139221B1/ko
Priority to US08/084,764 priority patent/US5399572A/en
Priority to HK44597A priority patent/HK44597A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8900564A 1989-02-17 1989-02-17 Novel medicinal use SE8900564D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE8900564A SE8900564D0 (sv) 1989-02-17 1989-02-17 Novel medicinal use
IL9324390A IL93243A (en) 1989-02-17 1990-02-01 Preparations for the prevention of neurodegeneration
IE46090A IE64622B1 (en) 1989-02-17 1990-02-09 Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
PH40041A PH26372A (en) 1989-02-17 1990-02-12 Novel medicinal use of 5-(2-chloroethyl)-4-methylthiazole or a salt or solvate thereof
ES90903980T ES2055421T3 (es) 1989-02-17 1990-02-13 Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.
JP2503995A JP3007683B2 (ja) 1989-02-17 1990-02-13 新規な医薬用途
EP90903980A EP0458892B1 (en) 1989-02-17 1990-02-13 Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
AT90903980T ATE107166T1 (de) 1989-02-17 1990-02-13 Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
DK90903980.2T DK0458892T3 (da) 1989-02-17 1990-02-13 Anvendelse af chlormethiazol ved fremstillingen af et medikament til forebyggelsen og/eller behandlingen af neurodegeneration
CA002045618A CA2045618A1 (en) 1989-02-17 1990-02-13 Medicinal use
AU51679/90A AU643431B2 (en) 1989-02-17 1990-02-13 Use of chlormethiazole in the prevention and/or treatment of neurodegeneration
DE69009989T DE69009989T2 (de) 1989-02-17 1990-02-13 Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
NZ232499A NZ232499A (en) 1989-02-17 1990-02-13 Pharmaceutical composition comprising 5-(2-chloro-ethyl)-4-methylthiazole
PCT/SE1990/000093 WO1990009174A1 (en) 1989-02-17 1990-02-13 Use of chlormethiazole in the prevention and/or treatment of neurodegeneration
KR91700916A KR0139221B1 (en) 1989-02-17 1991-08-16 Use of chlormethiazole in the prevention and/or treatment of neurodegeneration
US08/084,764 US5399572A (en) 1989-02-17 1993-06-28 Chlormethiazole in the treatment of neurodegeneration
HK44597A HK44597A (en) 1989-02-17 1997-04-10 Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900564A SE8900564D0 (sv) 1989-02-17 1989-02-17 Novel medicinal use

Publications (1)

Publication Number Publication Date
SE8900564D0 true SE8900564D0 (sv) 1989-02-17

Family

ID=20375091

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900564A SE8900564D0 (sv) 1989-02-17 1989-02-17 Novel medicinal use

Country Status (16)

Country Link
EP (1) EP0458892B1 (ko)
JP (1) JP3007683B2 (ko)
KR (1) KR0139221B1 (ko)
AT (1) ATE107166T1 (ko)
AU (1) AU643431B2 (ko)
CA (1) CA2045618A1 (ko)
DE (1) DE69009989T2 (ko)
DK (1) DK0458892T3 (ko)
ES (1) ES2055421T3 (ko)
HK (1) HK44597A (ko)
IE (1) IE64622B1 (ko)
IL (1) IL93243A (ko)
NZ (1) NZ232499A (ko)
PH (1) PH26372A (ko)
SE (1) SE8900564D0 (ko)
WO (1) WO1990009174A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921128B1 (en) * 1991-10-30 1998-10-31 Sandor Garaczy Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof
SE9802119D0 (sv) * 1998-06-15 1998-06-15 Astra Ab New use
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE196140C1 (ko) * 1964-01-01

Also Published As

Publication number Publication date
EP0458892B1 (en) 1994-06-15
NZ232499A (en) 1992-12-23
KR0139221B1 (en) 1998-05-15
ATE107166T1 (de) 1994-07-15
AU5167990A (en) 1990-09-05
KR920700641A (ko) 1992-08-10
PH26372A (en) 1992-06-01
DE69009989T2 (de) 1994-10-13
ES2055421T3 (es) 1994-08-16
DK0458892T3 (da) 1994-08-15
EP0458892A1 (en) 1991-12-04
IL93243A0 (en) 1990-11-29
IE900460L (en) 1990-08-17
IL93243A (en) 1994-08-26
JP3007683B2 (ja) 2000-02-07
WO1990009174A1 (en) 1990-08-23
HK44597A (en) 1997-04-18
IE64622B1 (en) 1995-08-23
AU643431B2 (en) 1993-11-18
CA2045618A1 (en) 1990-08-18
DE69009989D1 (de) 1994-07-21

Similar Documents

Publication Publication Date Title
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
NO891896L (no) Fremgangsmaate og innretning for behandling av medisinsk spesialavfall.
NO900613D0 (no) Fremgangsmaate for fremstilling av aktiverte chitosaner oganvendelse ved fremstilling av chitosanderivater.
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
DE69019363T2 (de) Desinfizierende zusammensetzung und desinfektionsverfahren.
DE69000467T2 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
PT87554A (pt) Didinfecting and sterilizing composition
DE3850433T2 (de) Allergiebehandlung und Zusammensetzung dafür.
BR8805425A (pt) Composicao de organopolissiloxano e utilizacao da mesma
NO922136D0 (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
EP0437026A3 (en) Use of tandospirone in the treatment of depression
NO921993D0 (no) Fremgangsmaate for efterbehandling av amfotaere eller zwitterioniske tensider
NO905291D0 (no) Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer.
BR8805426A (pt) Composicao de organopolissiloxano e utilizacao da mesma
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
SE8900564D0 (sv) Novel medicinal use
FI911644A (fi) Terapeutisk foerening och komposition.
DE69112921D1 (de) Hygiene- und Behandlungsvorrichtung.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO890816D0 (no) De-emulgeringsblandinger og fremgangsmaate ved fremstilling og anvendelse derav.
FI911638A0 (fi) Anordning foer soekning och stimulering av akupunkturstaellen.
NO905221D0 (no) Steriliseringsblandinger og anvendelse derav.
IL68422A0 (en) Hydantoin derivatives and their use in medicine
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물